Repligen Corp financial data

Symbol
RGEN on Nasdaq
Industry
Biological Products, (No Diagnostic Substances)
Location
41 Seyon Street, Building 1, Suite 100, Waltham, MA
Fiscal year end
December 31
Latest financial report
10-Q - Q1 2025 - Apr 29, 2025

Key Ratios

Label TTM Value / Value Unit Change %
Current Ratio 781 % +106%
Quick Ratio 119 % +55.5%
Debt-to-equity 43 % +16.3%
Return On Equity -1.15 % -196%
Return On Assets -0.81 % -192%

Shares

Label TTM Value / Value Unit Change %
Entity Common Stock, Shares Outstanding 56.1M shares +0.49%
Common Stock, Shares, Outstanding 56.2M shares +0.61%
Entity Public Float 5.98B USD -13.7%
Common Stock, Value, Issued 562K USD +0.54%

Income Statement

Label TTM Value / Value Unit Change %
Research and Development Expense 44.9M USD +7.37%
Costs and Expenses 683M USD +17.2%
Operating Income (Loss) -32.3M USD -186%
Nonoperating Income (Expense) 9.5M USD +123%
Income (Loss) from Continuing Operations before Income Taxes, Noncontrolling Interest -22.8M USD -154%
Income Tax Expense (Benefit) 193K USD -98.9%
Net Income (Loss) Attributable to Parent -23M USD -198%
Earnings Per Share, Basic -0.42 USD/shares -200%
Earnings Per Share, Diluted -0.42 USD/shares -200%

Balance Sheet

Label TTM Value / Value Unit Change %
Cash and Cash Equivalents, at Carrying Value 697M USD -10.7%
Accounts Receivable, after Allowance for Credit Loss, Current 147M USD +27.3%
Inventory, Net 153M USD -22.7%
Other Assets, Current 12.1M USD -8.93%
Assets, Current 1.03B USD -8.72%
Deferred Income Tax Assets, Net 737K USD -14.9%
Property, Plant and Equipment, Net 196M USD -4.96%
Operating Lease, Right-of-Use Asset 130M USD -3.67%
Intangible Assets, Net (Excluding Goodwill) 409M USD +3.73%
Goodwill 1.08B USD +9.78%
Other Assets, Noncurrent 2.11M USD +121%
Assets 2.85B USD -0.05%
Accounts Payable, Current 26.9M USD +43.8%
Employee-related Liabilities, Current 23.5M USD +14.5%
Accrued Liabilities, Current 76M USD +28.4%
Liabilities, Current 152M USD -16.3%
Operating Lease, Liability, Noncurrent 139M USD -3.88%
Other Liabilities, Noncurrent 17.1M USD +51.5%
Liabilities 867M USD -2.41%
Accumulated Other Comprehensive Income (Loss), Net of Tax -47.8M USD -11.4%
Retained Earnings (Accumulated Deficit) 413M USD -5.27%
Stockholders' Equity Attributable to Parent 1.99B USD +1.01%
Liabilities and Equity 2.85B USD -0.05%

Popular Metrics

Label TTM Value / Value Unit Change %
Net Cash Provided by (Used in) Operating Activities 15M USD -66.4%
Net Cash Provided by (Used in) Financing Activities -5.03M USD +43.9%
Net Cash Provided by (Used in) Investing Activities -74.1M USD -786%
Common Stock, Shares Authorized 80M shares 0%
Common Stock, Shares, Issued 56.2M shares +0.61%
Common Stock, Par or Stated Value Per Share 0.01 USD/shares 0%
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect -60.1M USD -305%
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents 697M USD -10.7%
Deferred Tax Assets, Valuation Allowance 517K USD +2485%
Deferred Tax Assets, Gross 106M USD +26.6%
Operating Lease, Liability 161M USD +21.5%
Payments to Acquire Property, Plant, and Equipment 3.56M USD -57.3%
Comprehensive Income (Loss), Net of Tax, Attributable to Parent -27.9M USD -332%
Lessee, Operating Lease, Liability, to be Paid 196M USD -2.92%
Property, Plant and Equipment, Gross 367M USD +7.61%
Operating Lease, Liability, Current 15.2M USD +54.9%
Lessee, Operating Lease, Liability, to be Paid, Year Two 27.3M USD +6.42%
Lessee, Operating Lease, Liability, to be Paid, Year One 24.5M USD +8.61%
Operating Lease, Weighted Average Discount Rate, Percent 0.05 pure 0%
Deferred Income Tax Expense (Benefit) -1.2M USD -7.31%
Lessee, Operating Lease, Liability, Undiscounted Excess Amount 32.1M USD -1.65%
Lessee, Operating Lease, Liability, to be Paid, Year Three 25.9M USD +1.76%
Deferred Tax Assets, Operating Loss Carryforwards 9.88M USD +29.1%
Preferred Stock, Shares Issued 0 shares
Preferred Stock, Shares Authorized 5M shares 0%
Unrecognized Tax Benefits 2.13M USD -32.2%
Lessee, Operating Lease, Liability, to be Paid, Year Four 26.1M USD +8.81%
Preferred Stock, Shares Outstanding 0 shares
Amortization of Intangible Assets 35.1M USD +6.69%
Deferred Tax Assets, Net of Valuation Allowance 106M USD +26%
Interest Expense 11.3M USD +887%
Preferred Stock, Par or Stated Value Per Share 0.01 USD/shares 0%